产品介绍
戊型病毒性肝炎是一种自愈性传染病,其传播方式、临床表现和预后均与甲型肝炎(甲肝)类似,孕妇患戊肝病死率高为本型肝炎的特点。
|
EV64
|
rAg
|
|
E.coli
|
包被/标记
|
酶免、发光、层析
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Human MET/c-Met/HGFR Recombinant Antibody, PE|抗人MET/c-Met/HGFR重组抗体,PE标记(靶标:间质-上皮转化因子/c-Met/肝细胞生长因子受体) |
325 |
| Anti-Human CD228/MELTF Recombinant Antibody, PE|抗人CD228/MELTF重组抗体,PE标记(靶标:黑素转铁蛋白/CD228) |
351 |
| Anti-Human ADRB1 Recombinant Antibody, PE|抗人ADRB1重组抗体,PE标记(靶标:β1肾上腺素能受体) |
259 |
| Anti-Human CD16 Recombinant Antibody, PE|抗人CD16重组抗体,PE标记(靶标:IgG Fc段受体III/CD16) |
506 |
| Anti-Human CD16a/FCGR3A Recombinant Antibody, PE|抗人CD16a/FCGR3A重组抗体,PE标记(靶标:IgG Fc段受体IIIa/CD16a) |
475 |
| Anti-Human CD49e/ITGA5 Recombinant Antibody , PE|抗人CD49e/ITGA5重组抗体,PE标记(靶标:整合素α5亚基/CD49e) |
340 |
| Anti-Human VIM/Vimentin Recombinant Antibody, PE|抗人VIM/波形蛋白重组抗体,PE标记(靶标:波形蛋白) |
157 |
| Anti-Human VIM/Vimentin Recombinant Antibody , PE|抗人VIM/波形蛋白重组抗体,PE标记(靶标:波形蛋白) |
396 |
| Anti-Human KRT19/CK19 Recombinant Antibody , PE|抗人KRT19/CK19重组抗体,PE标记(靶标:角蛋白19/细胞角蛋白19) |
250 |
| Anti-Human CD126/IL6R/IL-6RA Recombinant Antibody , PE|抗人CD126/IL6R/IL-6RA重组抗体,PE标记(靶标:白细胞介素6受体/CD126) |
297 |
| Anti-Human CD126/IL6R/IL-6RA Recombinant Antibody , PE|抗人CD126/IL6R/IL-6RA重组抗体,PE标记(靶标:白细胞介素6受体/CD126) |
235 |
| Anti-Human CD63/LAMP3 Recombinant Antibody, PE|抗人CD63/LAMP3重组抗体,PE标记(靶标:溶酶体相关膜蛋白3/CD63) |
162 |
| Anti-Human CD63/LAMP3 Recombinant Antibody , PE|抗人CD63/LAMP3重组抗体,PE标记(靶标:溶酶体相关膜蛋白3/CD63) |
358 |
| Anti-Human FGF2/bFGF Recombinant Antibody , PE|抗人FGF2/bFGF重组抗体,PE标记(靶标:成纤维细胞生长因子2/碱性成纤维细胞生长因子) |
426 |
| Anti-Human CD48 Recombinant Antibody , PE|抗人CD48重组抗体,PE标记(靶标:CD48分子) |
136 |
| Anti-Human CD48 Recombinant Antibody, PE|抗人CD48重组抗体,PE标记(靶标:CD48分子) |
455 |
| Anti-Human CXCL1/NAP-3/GRO-alpha Recombinant Antibody , PE|抗人CXCL1/NAP-3/GRO-α重组抗体,PE标记(靶标:CXC趋化因子配体1/中性粒细胞活化肽-3/生长调节癌基因α) |
175 |
| Anti-Human CD7 Recombinant Antibody, PE|抗人CD7重组抗体,PE标记(靶标:CD7分子) |
163 |
| Anti-Human CD7 Recombinant Antibody, PE|抗人CD7重组抗体,PE标记(靶标:CD7分子) |
170 |
| Anti-Human CSF1/M-CSF Recombinant Antibody , PE|抗人CSF1/M-CSF重组抗体,PE标记(靶标:集落刺激因子1/巨噬细胞集落刺激因子) |
241 |